ALX Oncology Holdings Analyst Ratings
ALX Oncology Holdings Analyst Ratings
Buy Rating for ALX Oncology Amid Impressive Evorpacept and Padcev Combination Trial Results
Analysts Offer Insights on Healthcare Companies: ALX Oncology Holdings (ALXO), Mirum Pharmaceuticals (MIRM) and IDEAYA Biosciences (IDYA)
Piper Sandler Sticks to Its Buy Rating for ALX Oncology Holdings (ALXO)
Analysts Offer Insights on Healthcare Companies: ALX Oncology Holdings (ALXO), Lantern Pharma (LTRN) and OmniAb (OABI)
ALX Oncology Holdings Analyst Ratings
ALX Oncology Holdings Analyst Ratings
Buy Rating on ALX Oncology Holdings Amid Strong Clinical Data and Favorable RNPV Analysis
Analysts' Top Healthcare Picks: Alnylam Pharma (ALNY), ALX Oncology Holdings (ALXO)
ALX Oncology Holdings Analyst Ratings
Stifel Downgrades ALX Oncology to Hold, Sees Evorpacept as Fully Valued
ALX Oncology Holdings Analyst Ratings
Analysts Are Bullish on Top Healthcare Stocks: Haemonetics (HAE), ALX Oncology Holdings (ALXO)
Jefferies Upgrades ALX Oncology Holdings to Buy, Raises Price Target to $18
ALX Oncology Holdings Analyst Ratings
Promising Interim Data and Financial Stability Prompt Buy Rating for ALX Oncology Holdings
Stifel Maintains Buy on ALX Oncology Holdings, Lowers Price Target to $10
ALX Oncology Holdings Analyst Ratings
Piper Sandler Sticks to Its Buy Rating for ALX Oncology Holdings (ALXO)